46 results on '"Isquith, Daniel"'
Search Results
2. Dapagliflozin Reduces Systemic Inflammation in Patients with Type 2 Diabetes Without Known Heart Failure
3. Lp(a) (Lipoprotein(a)) Levels Predict Progression of Carotid Atherosclerosis in Subjects With Atherosclerotic Cardiovascular Disease on Intensive Lipid Therapy
4. Metabolic and inflammatory risk reduction in response to lipid-lowering and lifestyle modification in the medically underserved individuals
5. Regression in carotid plaque lipid content and neovasculature with PCSK9 inhibition: A time course study
6. Serial magnetic resonance imaging detects a rapid reduction in plaque lipid content under PCSK9 inhibition with alirocumab
7. Mortality reduction in patients treated with long-term intensive lipid therapy: 25-year follow-up of the Familial Atherosclerosis Treatment Study—Observational Study
8. High-resolution MRI assessed carotid atherosclerotic plaque characteristics comparing men and women with elevated ApoB levels
9. Low levels of ApoA1 improve risk prediction of type 2 diabetes mellitus
10. Longer duration of statin therapy is associated with decreased carotid plaque vascularity by magnetic resonance imaging
11. Clinical Factors Associated With High-Risk Carotid Plaque Features as Assessed by Magnetic Resonance Imaging in Patients With Established Vascular Disease (from the AIM-HIGH Study)
12. Effects of Niacin on Glucose Levels, Coronary Stenosis Progression, and Clinical Events in Subjects With Normal Baseline Glucose Levels (
13. Carotid magnetic resonance imaging for monitoring atherosclerotic plaque progression: a multicenter reproducibility study
14. Comparison of Sleep/Wake Behavior in CKD Stages 4 to 5 and Hemodialysis Populations Using Wrist Actigraphy
15. Carotid Plaque Lipid Content Is Reduced After 6 Months of PCSK9 Inhibition with Alirocumab
16. Lipoprotein (a) levels predict progression of carotid atherosclerosis in subjects with atherosclerotic cardiovascular disease on intensive lipid therapy: an analysis of the AIM-HIGH Carotid MRI Sub-study
17. Abstract 17357: Magnetic Resonance Imaging Detected Intraplaque Hemorrhage and Expansive Remodeling in Superficial Femoral Artery
18. GW29-e0156 Pregnancy-associated plasma protein-A is a stronger predictor for adverse cardiovascular outcomes after acute coronary syndrome in type-2 diabetes mellitus
19. Treatment Effects of Different Lipid Lowering Regimens on Remnant Cholesterol
20. SUBSTANTIAL AND RAPID INCREASE IN CARDIOVASCULAR RISK BURDEN IN AN URBAN COMMUNITY-BASED POPULATION IN CHINA
21. Niacin therapy increases HDL particles and total cholesterol efflux capacity but not ABCA1-specific cholesterol efflux in statin-treated subjects
22. Differences in Cholesterol Efflux Capacity Mediated by the ABCA1, ABCG1 and SR-B1 Pathways in Patients With Acute Coronary Syndrome and Stable Coronar
23. Pregnancy-associated plasma protein-A is a stronger predictor for adverse cardiovascular outcomes after acute coronary syndrome in type-2 diabetes mellitus
24. Carotid Plaque Lipid Content and Fibrous Cap Status Predict Systemic CV Outcomes
25. Lifetime Cardiovascular Risk Reduction With Intensive Lipid Therapy: 25-Year Follow-Up Of The Familial Atherosclerosis Treatment Study – Observational
26. Summary of clinical and laboratory data of study subjects with and without DCE-MRI plaque measurements in the AIM-HIGH clinical trial
27. Niacin Therapy Increases High-Density Lipoprotein Particles and Total Cholesterol Efflux Capacity But Not ABCA1-Specific Cholesterol Efflux in Statin-Treated Subjects
28. HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity
29. Abstract 366: Gender Differences Exist in Carotid Arterial Plaque Composition Among Men and Women with Carotid or Coronary Artery Disease and Elevated ApoB Levels
30. Abstract 576: Gender Differences in Carotid Artery Plaque Composition Do Not Exist in Response to Lipid Lowering Therapy at Two Years Among Men and Women with Carotid or Coronary Artery Disease and Elevated ApoB Levels
31. Abstract 16722: Changes in Carotid Wall Morphology and Plaque Composition in Patients With Established Vascular Disease and Treated With Intensive Lipid Therapy in the AIM-HIGH Study
32. Abstract 16514: Magnetic Resonance Imaging-Detected Carotid Plaque Characteristics Predict Systemic Cardiovascular Outcomes in Patients With Clinically Established Atherosclerosis in the AIH-HIGH Study
33. Carotid magnetic resonance imaging for monitoring atherosclerotic plaque progression: a multicenter reproducibility study
34. Scan-rescan reproducibility of quantitative assessment of inflammatory carotid atherosclerotic plaque using dynamic contrast-enhanced 3T CMR in a multi-center study
35. Pregnancy-associated plasma protein-A is a stronger predictor for adverse cardiovascular outcomes after acute coronary syndrome in type-2 diabetes mellitus.
36. Magnetic Resonance Imaging of Intraplaque Hemorrhage and Plaque Lipid Content With Continued Lipid-Lowering Therapy: Results of a Magnetic Resonance Imaging Substudy in AIM-HIGH.
37. Carotid Vessel Wall Volume Decreases with Intensive Lipid Therapy in Plaque with and without Lipid Rich Necrotic Core
38. Calcified Plaque is Associated with Less Neovascularization and Lower Permeability as Assessed by Dynamic Contrast Enhanced MRI
39. MORTALITY REDUCTION IN PATIENTS TREATED WITH LONG-TERM INTENSIVE LIPID THERAPY: 20-YEAR FOLLOW-UP OF THE FAMILIAR ATHEROSCLEROSIS TREATMENT STUDY- OBSERVATIONAL STUDY
40. Change in Carotid Intima-Media Thickness and Association with Carotid Plaque After Prolonged Lipid Therapy∗
41. Scan-rescan reproducibility of quantitative assessment of inflammatory carotid atherosclerotic plaque using dynamic contrast-enhanced 3T CMR in a multi-center study.
42. Abstract 13903: Metabolic and Inflammatory Risk During Lipid-Lowering and Lifestyle Therapy in Underserved Populations
43. Abstract 12706: Carotid Plaque Lipid Content is Reduced After 6 Months of Proprotein Convertase Subtilisin Kexin Type 9 Inhibition With Alirocumab: an Interim Analysis of a Serial Magnetic Resonance Imaging Study
44. Clinical Factors Associated With High-Risk Carotid Plaque Features as Assessed by Magnetic Resonance Imaging in Patients With Established Vascular Disease (from the AIM-HIGH Study).
45. Dapagliflozin Reduces Systemic Inflammation in Patients with Type 2 Diabetes Without Known Heart Failure.
46. Summary of clinical and laboratory data of study subjects with and without DCE-MRI plaque measurements in the AIM-HIGH clinical trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.